Drug Type Small molecule drug |
Synonyms 阿莫西林氨溴索 |
Target |
Action modulators, inhibitors |
Mechanism SCNA modulators(Sodium voltage-gated channel alpha subunits modulators), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H21N3O6S |
InChIKeyAIPFZZHNBUVELL-YWUHCJSESA-N |
CAS Registry61336-70-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Bronchitis | Phase 1 | China | - | 07 May 2014 |
| Acute respiratory infections | Phase 1 | China | - | 07 May 2014 |
| Asthma | Phase 1 | China | - | 07 May 2014 |
| Asthmatic bronchitis | Phase 1 | China | - | 07 May 2014 |
| Bronchiectasis | Phase 1 | China | - | 07 May 2014 |
| Bronchitis, Chronic | Phase 1 | China | - | 07 May 2014 |
| Otitis Media | Phase 1 | China | - | 07 May 2014 |
| Pharyngitis | Phase 1 | China | - | 07 May 2014 |
| respiratory tract; infection, chronic | Phase 1 | China | - | 07 May 2014 |





